176 related articles for article (PubMed ID: 10405124)
21. Alteration of blood-brain barrier in human brain tumors: comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET.
Roelcke U; Radü EW; von Ammon K; Hausmann O; Maguire RP; Leenders KL
J Neurol Sci; 1995 Sep; 132(1):20-7. PubMed ID: 8523026
[TBL] [Abstract][Full Text] [Related]
22. FDG-PET evaluation of therapeutic effects on VX2 liver tumor.
Oya N; Nagata Y; Tamaki N; Takagi T; Murata R; Magata Y; Abe M; Konishi J
J Nucl Med; 1996 Feb; 37(2):296-302. PubMed ID: 8667065
[TBL] [Abstract][Full Text] [Related]
23. [Differential diagnosis of local tumor recurrence or radionecrosis after stereotactic radiosurgery for treatment of brain metastasis].
Patsouris A; Augereau P; Tanguy JY; Morel O; Menei P; Rousseau A; Paumier A
Cancer Radiother; 2014 Mar; 18(2):142-6. PubMed ID: 24433952
[TBL] [Abstract][Full Text] [Related]
24. Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas--comparison with gliomas.
Tsuyuguchi N
Osaka City Med J; 1997 Dec; 43(2):209-23. PubMed ID: 9540343
[TBL] [Abstract][Full Text] [Related]
25. Three-dimensional stereotactic surface projection analysis of macaque brain PET: development and initial applications.
Cross DJ; Minoshima S; Nishimura S; Noda A; Tsukada H; Kuhl DE
J Nucl Med; 2000 Nov; 41(11):1879-87. PubMed ID: 11079499
[TBL] [Abstract][Full Text] [Related]
26. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery.
Chao ST; Suh JH; Raja S; Lee SY; Barnett G
Int J Cancer; 2001 Jun; 96(3):191-7. PubMed ID: 11410888
[TBL] [Abstract][Full Text] [Related]
27. FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma.
Fischman AJ; Thornton AF; Frosch MP; Swearinger B; Gonzalez RG; Alpert NM
J Nucl Med; 1997 Jul; 38(7):1027-9. PubMed ID: 9225785
[TBL] [Abstract][Full Text] [Related]
28. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.
Minn H; Lapela M; Klemi PJ; Grénman R; Leskinen S; Lindholm P; Bergman J; Eronen E; Haaparanta M; Joensuu H
J Nucl Med; 1997 Dec; 38(12):1907-11. PubMed ID: 9430467
[TBL] [Abstract][Full Text] [Related]
29. 18F alpha-methyl tyrosine PET studies in patients with brain tumors.
Inoue T; Shibasaki T; Oriuchi N; Aoyagi K; Tomiyoshi K; Amano S; Mikuni M; Ida I; Aoki J; Endo K
J Nucl Med; 1999 Mar; 40(3):399-405. PubMed ID: 10086702
[TBL] [Abstract][Full Text] [Related]
30. Effects of hyperglycemia on FDG uptake in human brain and glioma.
Ishizu K; Nishizawa S; Yonekura Y; Sadato N; Magata Y; Tamaki N; Tsuchida T; Okazawa H; Miyatake S; Ishikawa M
J Nucl Med; 1994 Jul; 35(7):1104-9. PubMed ID: 8014665
[TBL] [Abstract][Full Text] [Related]
31. Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors.
Marriott CJ; Thorstad W; Akabani G; Brown MT; McLendon RE; Hanson MW; Coleman RE
J Nucl Med; 1998 Aug; 39(8):1376-80. PubMed ID: 9708511
[TBL] [Abstract][Full Text] [Related]
32. Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors.
Ross DA; Sandler HM; Balter JM; Hayman JA; Archer PG; Auer DL
J Neurooncol; 2002 Jan; 56(2):175-81. PubMed ID: 11995819
[TBL] [Abstract][Full Text] [Related]
33. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of semiquantitative FDG-PET in the prediction of brain tumor treatment response to gamma knife radiosurgery.
Lee JK; Liu RS; Shiang HR; Pan DH
J Comput Assist Tomogr; 2003; 27(4):525-9. PubMed ID: 12886136
[TBL] [Abstract][Full Text] [Related]
35. Can the standardized uptake value characterize primary brain tumors on FDG-PET?
Hustinx R; Smith RJ; Benard F; Bhatnagar A; Alavi A
Eur J Nucl Med; 1999 Nov; 26(11):1501-9. PubMed ID: 10552096
[TBL] [Abstract][Full Text] [Related]
36. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
[TBL] [Abstract][Full Text] [Related]
37. Radiographic response of brain metastasis after linear accelerator radiosurgery.
Rahman M; Cox JB; Chi YY; Carter JH; Friedman WA
Stereotact Funct Neurosurg; 2012; 90(2):69-78. PubMed ID: 22286386
[TBL] [Abstract][Full Text] [Related]
38. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
[TBL] [Abstract][Full Text] [Related]
39. [Therapeutic results of the treatment brain tumors using radiosurgery and stereotactic radiotherapy].
Doleželová H; Hynková L; Pospíšil P; Kazda T; Slampa P; Coupková I; Siková I; Fardus P; Svoboda T; Garčic J; Vrzal M; Selingerová I; Horová I
Klin Onkol; 2012; 25(6):445-51. PubMed ID: 23301647
[TBL] [Abstract][Full Text] [Related]
40. FDG PET for detection and therapy control of metastatic germ cell tumor.
Cremerius U; Effert PJ; Adam G; Sabri O; Zimmy M; Wagenknecht G; Jakse G; Buell U
J Nucl Med; 1998 May; 39(5):815-22. PubMed ID: 9591582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
